These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6454463)

  • 1. [Comparative study of the antimitotic effects of cyclophosphamide, trofosfamide and ifosfamide on meristema plant cells and animal cells in in vitro culture].
    Deysson G; Adolphe M; Semont H
    C R Seances Soc Biol Fil; 1981; 175(2):177-81. PubMed ID: 6454463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the antimitotic properties of cyclophosphamide and its biotransformation products on meristema plant cells and animal cells in in vitro culture].
    Deysson G; Adolphe M; Semont H
    C R Seances Soc Biol Fil; 1981; 175(2):182-6. PubMed ID: 6454464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of three alkylating antimitotic agents and their metabolites on in vitro monogranulocytic colony forming cells from mouse bone marrow.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Arzneimittelforschung; 1981; 31(3):470-3. PubMed ID: 7194671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of the three alkylating drugs, cyclophosphamide, ifosfamide and trofosfamide, with DNA and DNA-constituents in vitro (author's transl)].
    Lindemann H; Harbers E
    Arzneimittelforschung; 1980; 30(12):2075-80. PubMed ID: 7194064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
    Mohn GR; Ellenberger J
    Mutat Res; 1976; 32(3-4):331-60. PubMed ID: 822325
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C; Kis K; Issels R; Multhoff G
    Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells.
    Blomgren H; Hallström M
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):391-7. PubMed ID: 2747340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
    J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of sperm abnormalities in mice by ifosfamide and trofosfamide.
    Quinto I; De Marinis E; De Dominicis G; Della Morte R; Staiano N
    Mutat Res; 1988 Sep; 201(1):113-6. PubMed ID: 3419442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissues.
    Tew KD
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):24-7. PubMed ID: 7163812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
    Norpoth K; Addicks HW; Witting U; Mŭller G; Raidt H
    Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclophosphamide and ifosfamide on neuroblastoma cells before and after activation by microsomes.
    Meyer T; Wierse G; Weinrebe W; Treuner J; Niethammer D; Bruchelt G
    Anticancer Res; 1997; 17(2A):981-6. PubMed ID: 9137438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimitotic activity of 9 methoxy ellipticine lactate. Study on plant cells (Allium test) and on human cells cultivated in vitro].
    Bournique CP; Deysson G; Le Men J
    Ann Pharm Fr; 1972 Feb; 30(2):85-92. PubMed ID: 5051265
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the sensitivity of human cells in culture and of meristematic plant cells towards the action of antimitotic agents].
    Deysson G
    C R Seances Soc Biol Fil; 1974; 168(6-7):687-93. PubMed ID: 4282031
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
    Chen CS; Jounaidi Y; Waxman DJ
    Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
    Wagner A; Hempel G; Boos J
    Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.